Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning
Sponsor: Harch Hyperbaric Research Foundation
Listed as NCT00596180, this observational or N/A phase trial focuses on Neuropsychiatric Sequelae of Carbon Monoxide Poisoning and remains ongoing. Sponsored by Harch Hyperbaric Research Foundation, it has been updated 8 times since 2007, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2020 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
May 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting · Phase: PHASE1 → NA
-
Jan 2017 — May 2017 [monthly]
Unknown Status PHASE1
First recorded
Jan 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Harch Hyperbaric Research Foundation
- Paul G. Harch, M.D.
For direct contact, visit the study record on ClinicalTrials.gov .